The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Immortal time bias in observational studies of drug effects
Abstract
Purpose: Recent observational studies suggest that various drugs are remarkably effective at reducing morbidity and mortality. These cohort studies used a flawed approach to design and data analysis which can lead to immortal time bias. We describe the bias from 20 of these studies and illustrate it by showing that unrelated drugs can be made to appear effective at treating cardiovascular disease (CVD). Methods: The illustration used a cohort of 3315 patients, with chronic obstructive pulmonary disease (COPD), identified from the Saskatchewan Health databases, hospitalised for CVD and followed for up to a year. We used the biased approach to assess the effect of two medications, namely gastrointestinal drugs (GID) and inhaled beta‐agonists (IBA), both unknown to be effective in CVD, on the risk of all‐cause mortality. We also estimated these effects using the proper person‐time approach. Results: Using the inappropriate approach, the rates ratios of all‐cause death were 0.73 (95%CI: 0.57–0.93), with IBA and 0.78 (95%CI: 0.61–0.99), with GID. These rate ratios became 0.98 (95%CI: 0.77–1.25) and 0.94 (95%CI: 0.73–1.20), respectively, with the proper person‐time analysis. Conclusions: Several recent observational studies used a flawed approach to design and data analysis, leading to immortal time bias, which can generate an illusion of treatment effectiveness. Observational studies, with surprising beneficial drug effects should be re‐assessed to account for this source of bias. Copyright © 2007 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Epidemiology: Beyond the Basics
Szklo, M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.8.821 · Cited by 1,310
Inhaled Steroids and the Risk of Hospitalization for Asthma
Donahue, J. G. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540350037030 · Cited by 509
HMG-CoA Reductase Inhibitors and the Risk of Fractures
Meier, C. R. (2000) · JAMA · doi:10.1001/jama.283.24.3205 · Cited by 445
Zhou, Z., Rahme, E., Abrahamowicz, M., & Pilote, L. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi307 · Cited by 425 · cited 1×
“Several alternative approaches to the analysis of cohort studies to avoid misclassified immortal time were recently compared.(30) That paper was to some extent, confusing by its inaccurate designation of immortal time bias as ‘survival’ bias, which has another meaning altogether in epidemiology.”
MethodAntidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
SIN, D. D., & TU, J. V. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2009033 · Cited by 305
Soriano, J. B., Vestbo, J., Pride, N. B., Kiri, V., Maden, C., & Maier, W. C. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00301302 · Cited by 286
Suissa, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1231oc · Cited by 272
Self-citationUse of Statins and Risk of Fractures
van Staa, T.-P. (2001) · JAMA · doi:10.1001/jama.285.14.1850 · Cited by 271
Cited by
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Self-citationLevesque, L. E., Hanley, J. A., Kezouh, A., & Suissa, S. (2010) · BMJ · doi:10.1136/bmj.b5087 · Cited by 1,182
Self-citationBenza, R. L., Miller, D. P., Barst, R. J., Badesch, D. B., Frost, A. E., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-1460 · Cited by 1,104
Hernán, M. A., Sauer, B. C., Hernández-Díaz, S., Platt, R., & Shrier, I. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.04.014 · Cited by 1,097
Registries for Evaluating Patient Outcomes: A User’s Guide
(2020) · doi:10.23970/ahrqepcregistries4 · Cited by 960
Wu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818
Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637
Benza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Metformin and the Risk of Cancer
Suissa, S., & Azoulay, L. (2012) · Diabetes Care · doi:10.2337/dc12-0788 · Cited by 531
Self-citationThe test-negative design for estimating influenza vaccine effectiveness
Jackson, M. L., & Nelson, J. C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.053 · Cited by 510
Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Margulis, A. V., Pladevall, M., Riera-Guardia, N., Varas-Lorenzo, C., Hazell, L., Berkman, N., Viswanathan, M., & Perez-Gutthann, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s66677 · Cited by 441
Active-comparator design and new-user design in observational studies
Yoshida, K., Solomon, D. H., & Kim, S. C. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.30 · Cited by 406
Predictors of major infections in systemic lupus erythematosus
Ruiz-Irastorza, G., Olivares, N., Ruiz-Arruza, I., Martinez-Berriotxoa, A., Egurbide, M.-V., & Aguirre, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2764 · Cited by 374
When and how can real world data analyses substitute for randomized controlled trials?
Franklin, J. M., & Schneeweiss, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.857 · Cited by 316
The oligometastatic state—separating truth from wishful thinking
Palma, D. A., Salama, J. K., Lo, S. S., Senan, S., Treasure, T., Govindan, R., & Weichselbaum, R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.96 · Cited by 277
Graphical Depiction of Longitudinal Study Designs in Health Care Databases
Schneeweiss, S., Rassen, J. A., Brown, J. S., Rothman, K. J., Happe, L., Arlett, P., Dal Pan, G., Goettsch, W., Murk, W., & Wang, S. V. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3079 · Cited by 275
Shirani, A., Zhao, Y., Karim, M. E., Evans, C., Kingwell, E., van der Kop, M. L., Oger, J., Gustafson, P., Petkau, J., & Tremlett, H. (2012) · JAMA · doi:10.1001/jama.2012.7625 · Cited by 263
Huber-Wagner, S., Biberthaler, P., Häberle, S., Wierer, M., Dobritz, M., Rummeny, E., van Griensven, M., Kanz, K.-G., Lefering, R., & the TraumaRegister, D. G. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068880 · Cited by 252
Angiotensin inhibition in renovascular disease: A population-based cohort study
Hackam, D. G., Duong-Hua, M. L., Mamdani, M., Li, P., Tobe, S. W., Spence, J. D., & Garg, A. X. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.013 · Cited by 143
Franklin, J. M., Pawar, A., Martin, D., Glynn, R. J., Levenson, M., Temple, R., & Schneeweiss, S. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1633 · Cited by 119
A Structural Description of Biases That Generate Immortal Time
Hernán, M. A., Sterne, J. A. C., Higgins, J. P. T., Shrier, I., & Hernández-Díaz, S. (2025) · Epidemiology · doi:10.1097/ede.0000000000001808 · Cited by 99
Metformin and Cancer: Mounting Evidence Against an Association
Suissa, S., & Azoulay, L. (2014) · Diabetes Care · doi:10.2337/dc14-0500 · Cited by 93
Self-citationKumar, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr090 · Cited by 92
Douros, A., Ades, M., & Renoux, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0507-7 · Cited by 42
Pain treatments after hip fracture among older nursing home residents
Zullo, A. R., Zhang, T., Beaudoin, F. L., Lee, Y., McConeghy, K. W., Kiel, D. P., Daiello, L. A., Mor, V., & Berry, S. D. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.11.008 · Cited by 12
“Moreover, immortal time bias (follow-up time preceding the actual start of exposure to analgesics misclassified as exposed time) will become less of a concern because the exact date of the first non-opioid (non-prescription) analgesic dispensing can serve as the index date.[15] Finally, medication administration data…”
BackgroundWang, L.-J., Lee, S.-Y., Chou, W.-J., Lee, M.-J., Tsai, C.-S., Lee, T.-L., Yang, C.-J., Yang, K.-C., Chen, C.-K., & Shyu, Y.-C. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0126 · Cited by 9
Metadata
- Authors
- Suissa, S.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2007-01-25
- Volume
- 16
- Issue
- 3
- Pages
- 241-249
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2117317003
- Cited by
- 584
- References
- 28
- FWCI
- 19.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.